Clinical Trial Update: Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial compared ciprofloxacin to cefepime in febrile neutropenic patients with hematologic diseases. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Cefepime (cefepime)
• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Center for Supporting Hematology-Oncology Trials | Conditions: Febrile Neutropenia | Phase 3 | Status: COMPLETED